Literature DB >> 17391707

Fisher/Gullain-Barré overlap syndrome in advanced AIDS.

Akiyuki Hiraga1, Satoshi Kuwabara, Akira Nakamura, Nobuhiro Yuki, Takamichi Hattori, Takashi Matsunaga.   

Abstract

Human immunodeficiency virus-associated Guillain-Barré syndrome typically occurs early in HIV infection before AIDS develops. We report a 56-year-old male AIDS patient, who developed overlapping Fisher/Guillain-Barré syndrome despite markedly decreased CD4 cell counts. Serum anti-GQ1b IgG antibody was positive. His condition improved rapidly after immunoglobulin treatment. This indicates that Fisher/Guillain-Barré syndrome may occur even in severely immunosuppressed patients and that anti-ganglioside antibody production is possibly mediated by a T cell-independent process.

Entities:  

Mesh:

Year:  2007        PMID: 17391707     DOI: 10.1016/j.jns.2007.02.029

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Miller-Fisher syndrome following vaccination against influenza virus A/H1N1 in an AIDS patient.

Authors:  P Annunziata; N Carnicelli; P Galluzzi; F Pippi; P Almi; F Ginanneschi; P Gennari
Journal:  Infection       Date:  2011-08-30       Impact factor: 3.553

2.  Nuclear protein LEDGF/p75 recognizes supercoiled DNA by a novel DNA-binding domain.

Authors:  Kimiko M Tsutsui; Kuniaki Sano; Osamu Hosoya; Tadashi Miyamoto; Ken Tsutsui
Journal:  Nucleic Acids Res       Date:  2011-02-23       Impact factor: 16.971

3.  Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report.

Authors:  Derek J Sloan; Andrew Nicolson; Alastair R O Miller; Nick J Beeching; Mike B J Beadsworth
Journal:  J Med Case Rep       Date:  2008-12-04

Review 4.  Altered mental status in "Guillain-Barré syndrome" -a noteworthy clinical clue.

Authors:  Eoin Mulroy; Neil E Anderson
Journal:  Ann Clin Transl Neurol       Date:  2020-11-02       Impact factor: 5.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.